Alpha Lipoic Acid for Burning Mouth
NCT00387543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2011-04-05
Summary
Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.
Conditions
- Burning Sore Mouth
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Allison J. Bruce · Mayo Clinic
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
NCT02580734 ·Status: COMPLETED ·Phase: NA
-
A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
NCT00862576 ·Status: COMPLETED
-
Effect to the Photobiomodulation in the Burning Mouth Syndrome
NCT05871580 ·Status: COMPLETED ·Phase: NA
-
Effects of Photobiomodulation in Burning Mouth Syndrome
NCT04034849 ·Status: COMPLETED ·Phase: NA
-
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
NCT00504387 ·Status: UNKNOWN
-
Therapeutic Options for Treatment of Burning Mouth Syndrome
NCT04475614 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
NCT02757612 ·Status: COMPLETED ·Phase: NA
-
Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
NCT04313907 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
NCT04884503 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
NCT02690844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
NCT06217731 ·Status: COMPLETED ·Phase: NA
-
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
NCT01931293 ·Status: UNKNOWN ·Phase: NA
-
The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
NCT01754740 ·Status: COMPLETED ·Phase: NA
-
Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus
NCT06533033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Duration of Effect of Biotene Spray in Patients With Dry Mouth
NCT03663231 ·Status: COMPLETED ·Phase: NA
-
Burning Mouth Syndrome: Effects of Occlusal Splint Therapy
NCT07344909 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
NCT05309681 ·Status: COMPLETED
-
Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
NCT05403216 ·Status: COMPLETED
-
Lipid Based Food Additives for Treating Patients With Dry Mouth
NCT00422370 ·Status: UNKNOWN ·Phase: NA
-
Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.
NCT04265001 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics
NCT04704128 ·Status: COMPLETED
-
Clinical Evaluation of Oral Rinse for Xerostomia
NCT04289051 ·Status: COMPLETED ·Phase: NA
-
Oral Mucosal Absorption Study of Bicalutamide New Formulation
NCT01416883 ·Status: TERMINATED ·Phase: PHASE1
-
Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era
NCT04434014 ·Status: UNKNOWN
-
Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
NCT01425983 ·Status: COMPLETED ·Phase: PHASE3